BMXXY

$8.41-$0.45 (-5.12%)live

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

52-week range

$7.12 – $14.55

17% from low

Exchange

OTC Link

ADRC

Change$-92.50

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$4.1B	+0.6%	$0.00	$0.00–$0.00	—	0
2027	$4.3B	+5.2%	$0.00	$0.00–$0.00	—	0

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Intrinsic value

$9.57

Price

$8.41

Implied upside

+14%

Symbol	Price	Today	Mkt cap	P/E
BMXXYbioMérieux S.A.	$8.41	-5.12%	$9.9B	—
ALPMYAstellas Pharma Inc.	$14.72	+1.31%	$26.4B	—
GIKLYGrifols, S.A.	$5.10	+0.00%	$13.4B	—
GNMSFGenmab A/S	$310.63	-0.28%	$19.1B	—
ORINYOrion Oyj	$43.02	+0.00%	$24.2B	—
SAUHFStraumann Holding AG	$128.25	+0.00%	$20.4B	—

Source: Financial Modeling Prep · peers by sector/industry

No one on the platform currently holds BMXXY.

Institutions holding (13F)

No tracked institution reports a position in BMXXY as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

TTM yield · 3.65% ($0.31/share)

No one on the platform has traded BMXXY yet.